NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Milestone bariatric procedures at a Miami hospital mark the Florida debut of MARS®, a less invasive approach that reduces incisions, scarring, and recovery time.

Introducing Magnesium L-Theanine Complex™ for relaxation and restorative sleep, and TreBiome™, a full-spectrum pre-, pro-, and postbiotic supporting total microbiome balance and both gut and vaginal health.

The additional capacity at the Austin, Texas, center responds to sustained demand for adolescent residential mental health care, with the new beds expected to be available in August 2026.

The prestigious CMS recognition highlights White Plains Center for Nursing Care's commitment to clinical excellence, resident-centered care, and outstanding healthcare outcomes.

Shareholders Approve All Matters Presented at Meeting, Including New Long-Term Incentive Plan and Amendment to Constating Documents

This annual gathering recognizes the physicians, providers, and referral partners who are redefining collaborative patient care.

Neonorm^® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs

Jaguar expects to make Neonorm Dog available through both Amazon and Chewy

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for rare IF diseases, including MVID

Patent expands intellectual property protection in one of the world's largest cartilage repair markets

GelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need for cell harvesting, lab processing, and surgeries-potentially setting a new standard of care for knee cartilage repair

The collaboration will enable the development, validation, and application of advanced AI technologies to identify clinically meaningful patient subgroups, support biomarker-driven clinical trials, and create a platform for biopharma partnerships advancing innovation and personalized medicine.

72% of dentists say they're "very confident" hygiene appointments meet best-practice standards; only 29% of hygienists agree, according to a new survey of dental professionals from Alta Voice

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Hypertriglyceridemia

European Notified Body approves next-generation manufacturing process that increases production 5-fold, lowers manufacturing costs, improves safety and enables scalable commercial production

GelrinC^®, which is approved for sale in the European Union, is pioneering knee cartilage repair with an off-the-shelf cell-free hydrogel implant

The facility's 36-bed dual-diagnosis program offers a personalized treatment approach in a regional behavioral health system under growing strain

A national survey of 1,750 U.S. adults finds that frustration with the healthcare system runs deepest in midlife, not old age.

The Georgia rehab center is renewing its commitment to integrated care for individuals with co-occurring mental health and addiction disorders

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial

New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading outcomes, critical amid workforce shortages and rural care challenges

• Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failure

• Associated with significant toxicities to patients, PS has a lethal natural history, and PS reduction can potentially extend and save lives

Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpoint

New peer-reviewed data published in the scientific journal Cartilage uses the complete set of follow-up data from GelrinC's Phase II study, which establishes GelrinC as a leader in long-term durable cartilage repair, using objective, quantitative MOCART assessment to demonstrate morphologic outcomes that consistently outperform other treatment modalities

The data presented by Regentis show that two years after treatment, the repaired cartilage appears very close to normal healthy cartilage, highlighting the long-term durability of GelrinC and reinforcing its competitive superiority in the cartilage repair landscape

GelrinC is already approved in Europe and currently in a pivotal Phase III U.S. FDA study

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010

The Miami Beach keloid specialist outlines why pairing surgical excision with superficial radiation therapy can reduce recurrence and improve long-term comfort.

Legal action seeks to halt Jason Shurka and The Light System, Inc. from misappropriating EES intellectual property

Pedal Stronger: The Importance of Cycling and Physiotherapy

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants

LIVE FOREVER HEALTH^™ UNVEILS FULL-STACK HORMONE & TELEMEDICINE FRANCHISE MODEL, PIONEERING LONGEVITY CARE IN ALL 50 STATES

The Specialized Health Leader Offers a Turnkey System for Entrepreneurs to Capitalize on the Booming $27 Billion Hormone Replacement Market with Proven Clinical Protocols and Transparent Pricing.

Introducing the News: The Core Announcement

• In partnering with Aspire's BUZZ BOMB™ brand, Ashley joins a decorated athlete and fitness trainer roster fueled by the brand's industry-leading commitment to innovation

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure

Partnership strengthens global preparedness against a significant pandemic threat

If licensed and in the event of an influenza pandemic, Moderna will allocate 20% of its H5 pandemic vaccine manufacturing capacity for timely supply to low- and middle-income countries at affordable pricing

Excellence Recognized in Plastic Surgery, Med Spa, & Skin Care

Prosta Peak Reviews 2025 Safety Report: Ingredient Science, Real User Results, Pricing Analysis & Where to Buy the Authentic Formula

A Deep Dive Into Kerassential Ingredients, Real-World Results, Safety Data, Buyer Complaints & How to Avoid Counterfeit Versions in 2025

A science-driven 2025 investigation into Synadentix's enzyme technology, hydroxyapatite repair matrix, oral microbiome modulation, and real-world results reported by over 12,000 users

Company to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline

SBS-IF is the second orphan disease target indication for Jaguar's intestinal failure program, which includes microvillus inclusion disease (MVID) - for which the company completed a meeting in October 2025 with the FDA in support of a possible expedited approval pathway

EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availability

EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving more than 5,000 patients and, notably, has no warnings or adverse events related to sexual dysfunction and no clinically significant weight gain compared to placebo

mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)

mNEXSPIKE will be available in the European Union, subject to authorization by the European Commission